S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
OTCMKTS:PARNF

Parnell Pharmaceuticals Stock Forecast, Price & News

$0.37
0.00 (-0.67 %)
(As of 01/15/2021 08:27 PM ET)
Add
Compare
Today's Range
$0.37
Now: $0.37
$0.38
50-Day Range
$0.30
MA: $0.35
$0.39
52-Week Range
$0.04
Now: $0.37
$0.40
Volume30,000 shs
Average Volume27,866 shs
Market Capitalization$7.40 million
P/E RatioN/A
Dividend YieldN/A
Beta5
Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for improving cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product aids in the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also operates mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

MarketRank

Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PARNF
Previous SymbolNASDAQ:PARN
CUSIPN/A
CIKN/A
Phone61-2-9667-4411
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$7.40 million
Next Earnings DateN/A
OptionableNot Optionable
$0.37
0.00 (-0.67 %)
(As of 01/15/2021 08:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PARNF News and Ratings via Email

Sign-up to receive the latest news and ratings for PARNF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Parnell Pharmaceuticals (OTCMKTS:PARNF) Frequently Asked Questions

How has Parnell Pharmaceuticals' stock price been impacted by COVID-19?

Parnell Pharmaceuticals' stock was trading at $0.1001 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PARNF stock has increased by 269.6% and is now trading at $0.37.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Parnell Pharmaceuticals?

Wall Street analysts have given Parnell Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Parnell Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Parnell Pharmaceuticals?

Parnell Pharmaceuticals saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 4,500 shares, an increase of 87.5% from the December 15th total of 2,400 shares. Based on an average trading volume of 55,300 shares, the days-to-cover ratio is presently 0.1 days.
View Parnell Pharmaceuticals' Short Interest
.

Who are some of Parnell Pharmaceuticals' key competitors?

Who are Parnell Pharmaceuticals' key executives?

Parnell Pharmaceuticals' management team includes the following people:
  • Dr. Alan Richard Bell, Exec. Chairman (Age 65)
  • Mr. Brad R. McCarthy, CEO, CFO, Chief Accounting Officer, Company Sec. & Exec. Director (Age 45)

What is Parnell Pharmaceuticals' stock symbol?

Parnell Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PARNF."

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Parnell Pharmaceuticals' stock price today?

One share of PARNF stock can currently be purchased for approximately $0.37.

How big of a company is Parnell Pharmaceuticals?

Parnell Pharmaceuticals has a market capitalization of $7.40 million.

What is Parnell Pharmaceuticals' official website?

The official website for Parnell Pharmaceuticals is www.parnell.com.

How can I contact Parnell Pharmaceuticals?

Parnell Pharmaceuticals' mailing address is UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD, ALEXANDRIA C3, 2015. The company can be reached via phone at 61-2-9667-4411 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.